About Us

Biocodex at a glance

Present in more than 120 countries, Biocodex’s 1,626 employees are committed to serving millions of patients around the world. We apply our expertise to a wide range of products to meet patient needs, focusing on three pillars: the Microbiota Mission, orphan drugs and women’s health.

Biocodex key figures

  • An international pharmaceutical company serving patients in more than 120 countries
  • € 418M in revenue 2021
  • 3 pillars: the Microbiota Mission, orphan drugs and women’s health
  • Founded in 1953 to market Saccharomyces boulardii CNCM I-745®, the world’s first probiotic yeast strain for human medicine
  • More than 1,600 employees of 42 nationalities
  • 3 industrial facilities in France and Morocco
  • 1 R&D center in France
  • Subsidiaries in 20 countries
  • 114 distribution partners
  • An investor in 4 start-ups specialized in innovative health solutions

December 31, 2021 figures